Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Ozempic (semaglutide) 0.25 mg, 0.5 mg, 1 mg, and 2 mg injection pens, which are approved as treatments for Type 2 diabetes, will also be available for eligible patients based on individual clinical judgment
Most people who take GLP-1 drugs give themselves weekly or daily injections
If successful, survivors may recover compensation for expenses such as funeral costs and loss of financial support
Is it suitable during pregnancy or breastfeeding
Significant results accumulate over months, not days
Retatrutide may be worth waiting for if: You have not responded adequately to existing GLP-1 medications Your obesity is severe enough to benefit from the additional weight loss potential You have metabolic dysfunction-associated steatotic liver disease (MASLD/NAFLD) You are comfortable with a medication that has less real-world safety data You can wait for FDA approval without significant health deterioration Your cardiovascular status has been evaluated and heart rate increases are not contraindicated Retatrutide represents the next frontier
US$ 28.95
US$ 27.80
US$ 27.05
US$ 21.86
